Human Immunodeficiency Virus (HIV) – Epidemiology Forecast to 2029
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The diagnosed prevalent cases of human immunodeficiency virus (HIV) in the seven major markets (7MM*) are projected to increase from 1.87 million in 2019 to 2.1 million in 2029, with an annual growth rate (AGR) of 1.06%, according to GlobalData, a leading data and analytics company.
This report estimates that in 2029 the US will have the highest number of diagnosed prevalent cases of HIV across the 7MM with over 1.4 million cases, whereas Japan will have the lowest number with around 28,000 cases. In the *5EU, GlobalData estimates there to be nearly 640,000 diagnosed prevalent cases of HIV in 2029.
Natasha Karim, MPH, Managing Epidemiologist at GlobalData, says: “The rise in diagnosed prevalent cases are attributable to increases in the HIV diagnosis rate, significant and increasing historical trends in prevalence, and changes in the underlying population demographics.”
Scope
The Human Immunodeficiency Virus (HIV) Epidemiology Report and Model provide an overview of the risk factors, comorbidities, and global trends of HIV in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).The report includes a 10-year epidemiological forecast for the total prevalent cases of HIV, diagnosed prevalent cases of HIV, and diagnosed incident cases of HIV segmented by age (0–17 years, 18–29 years, and by 10-year age groups for age 30 years up to 80 years and older) and sex. Diagnosed prevalent cases are further segmented by coinfection with hepatitis B virus (HBV), coinfection with hepatitis C virus (HCV), and cases on antiretroviral therapy (ART). Lastly, the forecast includes the prophylactic population on pre-exposure prophylaxis (PrEP).
Key Highlights
GlobalData epidemiologists forecast that the total prevalent cases of HIV in the 7MM will increase from 2,134,989 cases in 2019 to 2,332,792 cases in 2029. Furthermore, GlobalData epidemiologists forecast that the diagnosed prevalent cases of HIV in the 7MM will increase from 1,871,183 cases in 2019 to 2,068,647 cases in 2029. Finally, GlobalData epidemiologists forecast that the diagnosed incident cases of HIV in the 7MM will increase from 65,128 cases in 2019 to 64,204 cases in 2029.
Reasons to Buy
The HIV Epidemiology series will allow you to:
- Develop business strategies by understanding the trends shaping and driving the global HIV markets.
- Quantify patient populations in the global HIV markets to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for HIV therapeutics in each of the markets covered.
Understand magnitude of the HIV population by age, sex, coinfection, and ART use.
- The HIV epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in HIV.
- The Epidemiology Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.
Table of Contents
Table
Figures
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.